Press Release Tag: Open Innovation

Read: BioMed X starts new schizophrenia research program with Boehringer Ingelheim

BioMed X starts new schizophrenia research program with Boehringer Ingelheim

• Jan 13, 2020

Read: BioMed X starts new research program in autoimmune diseases with Merck

BioMed X starts new research program in autoimmune diseases with Merck

• Jan 9, 2020

Read: BioMed X and Boehringer Ingelheim to investigate early intervention in psychiatric diseases

BioMed X and Boehringer Ingelheim to investigate early intervention in psychiatric diseases

• Jan 17, 2019

Read: BioMed X and Boehringer Ingelheim start new joint research group in bacterial modulation of innate immunity

BioMed X and Boehringer Ingelheim start new joint research group in bacterial modulation of innate immunity

• Nov 27, 2017

Read: BioMed X Announces Biomedical Research Collaboration with Janssen

BioMed X Announces Biomedical Research Collaboration with Janssen

• Oct 25, 2017

Read: BioMed X and Merck launch two new crowdsourcing projects in the fields of cancer research and biologics manufacturing

BioMed X and Merck launch two new crowdsourcing projects in the fields of cancer research and biologics manufacturing

• Jun 8, 2017

Read: BioMed X and Boehringer Ingelheim launch new crowdsourcing project to identify key regulatory mechanisms in innate immunity

BioMed X and Boehringer Ingelheim launch new crowdsourcing project to identify key regulatory mechanisms in innate immunity

• Feb 6, 2017

Read: BioMed X and Merck start new project in cancer research

BioMed X and Merck start new project in cancer research

• Nov 3, 2016

Read: BioMed X announces the start of new research team on Oral Biofilm Disruption through continued collaboration with Johnson & Johnson Innovation

BioMed X announces the start of new research team on Oral Biofilm Disruption through continued collaboration with Johnson & Johnson Innovation

• Sep 6, 2016

Read: Boehringer Ingelheim and BioMed X start new project to explore and develop unprecedented new treatment approaches for psychiatric diseases applying crowdsourcing

Boehringer Ingelheim and BioMed X start new project to explore and develop unprecedented new treatment approaches for psychiatric diseases applying crowdsourcing

• May 23, 2016

Read: BioMed X and Merck extend collaboration in cancer research

BioMed X and Merck extend collaboration in cancer research

• Mar 3, 2016

Read: BioMed X – Merck collaboration in the field of selective kinase inhibitors reaches major milestone

BioMed X – Merck collaboration in the field of selective kinase inhibitors reaches major milestone

• Jan 13, 2016

Read: Boehringer Ingelheim and BioMed X extend collaboration to discover novel therapeutic concepts for the treatment of psychiatric diseases

Boehringer Ingelheim and BioMed X extend collaboration to discover novel therapeutic concepts for the treatment of psychiatric diseases

• Nov 2, 2015

Read: Merck Serono and BioMed X extend collaboration

Merck Serono and BioMed X extend collaboration

• Jul 23, 2015

Read: Roche and BioMed X collaborate to develop nanomaterial-based biosensors for near-patient testing

Roche and BioMed X collaborate to develop nanomaterial-based biosensors for near-patient testing

• Feb 24, 2015

Read: Boehringer Ingelheim and BioMed X collaborate to discover new epigenetic regulators of COPD

Boehringer Ingelheim and BioMed X collaborate to discover new epigenetic regulators of COPD

• Jan 5, 2015

Read: Merck Serono Announces Collaboration with BioMed X Innovation Center in Heidelberg, Germany

Merck Serono Announces Collaboration with BioMed X Innovation Center in Heidelberg, Germany

• Apr 3, 2013